{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-091433","form_type":"8-K","ticker":"XWEL","cik":"0001410428","company_name":"XWELL, Inc.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.829026+00:00","generated_at":"2026-06-11T10:36:03.969756+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"XWELL Q2 2023 revenue down 40% YoY; net loss improves to $5.7M; CDC renews $15.9M biosurveillance contract","bullets":["Revenue $8.2M vs $13.6M in Q2 2022; XpresSpa revenue up 59% YoY.","Net loss attributable to common shareholders $5.7M, improved from $7.9M loss.","CDC renews biosurveillance program with contract value ~$15.9M; all XpresCheck locations closed.","Appointed Suzanne Scrabis as CFO effective July 10, 2023.","Cash and marketable securities $31.9M; no long-term debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-091433","json":"https://secwatch.observer/filing/0001104659-23-091433.json","markdown":"https://secwatch.observer/filing/0001104659-23-091433.md","text":"https://secwatch.observer/filing/0001104659-23-091433.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410428/000110465923091433/0001104659-23-091433-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410428/000110465923091433/tm2323722d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T10:36:03.969756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"28bea9dec1e4a642725c4919aab75eaabb6e6c54","claim":"XWELL, Inc. reported financial results for second quarter ended June 30, 2023.","evidence_excerpt":"XWELL, Inc., dated August 14, 2023, announcing certain operating results for the fiscal quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465923091433/0001104659-23-091433-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}